119 related articles for article (PubMed ID: 6691428)
1. Parkinsonian side effects induced by a monoamine oxidase inhibitor.
Teusink JP; Alexopoulos GS; Shamoian CA
Am J Psychiatry; 1984 Jan; 141(1):118-9. PubMed ID: 6691428
[TBL] [Abstract][Full Text] [Related]
2. Parkinsonism induced by a monoamine oxidase inhibitor.
Gillman MA; Sandyk R
Postgrad Med J; 1986 Mar; 62(725):235-6. PubMed ID: 3714615
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous remission of MAOI-induced anorgasmia.
Nurnberg HG; Levine PE
Am J Psychiatry; 1987 Jun; 144(6):805-7. PubMed ID: 3592004
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase inhibitor-induced speech blockage.
Goldstein DM; Goldberg RL
J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
[TBL] [Abstract][Full Text] [Related]
5. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
6. A case report of leukopenia associated with phenelzine.
Tipermas A; Gilman HE; Russakoff LM
Am J Psychiatry; 1984 Jun; 141(6):806-7. PubMed ID: 6731626
[TBL] [Abstract][Full Text] [Related]
7. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
[TBL] [Abstract][Full Text] [Related]
8. Adverse consequences of fluoxetine-MAOI combination therapy.
Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
[TBL] [Abstract][Full Text] [Related]
9. Refractory depression treated with high doses of monoamine oxidase inhibitor.
Guze BH; Baxter LR; Rego J
J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
[TBL] [Abstract][Full Text] [Related]
10. Case report of a toxic reaction from a combination of tryptophan and phenelzine.
Thomas JM; Rubin EH
Am J Psychiatry; 1984 Feb; 141(2):281-3. PubMed ID: 6691495
[TBL] [Abstract][Full Text] [Related]
11. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
[TBL] [Abstract][Full Text] [Related]
12. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
[TBL] [Abstract][Full Text] [Related]
13. Common side effects associated with monoamine oxidase inhibitors.
Remick RA; Froese C; Keller FD
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced catatonia.
Herrmann N; Lieff SJ
Can J Psychiatry; 1988 Oct; 33(7):633-4. PubMed ID: 3197020
[TBL] [Abstract][Full Text] [Related]
15. Severe daytime somnolence in patients treated with an MAOI.
Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic phenelzine treatment on REM sleep: report of three patients.
Landolt HP; de Boer LP
Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S63-7. PubMed ID: 11682276
[TBL] [Abstract][Full Text] [Related]
17. Delusional parasitosis associated with phenelzine.
Aizenberg D; Schwartz B; Zemishlany Z
Br J Psychiatry; 1991 Nov; 159():716-7. PubMed ID: 1756352
[TBL] [Abstract][Full Text] [Related]
18. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
Goff DC
Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
[TBL] [Abstract][Full Text] [Related]
19. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
Rabkin J; Quitkin F; Harrison W; Tricamo E; McGrath P
J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
[TBL] [Abstract][Full Text] [Related]
20. The combination of lithium carbonate and an MAOI in refractory depressions.
Fein S; Paz V; Rao N; LaGrassa J
Am J Psychiatry; 1988 Feb; 145(2):249-50. PubMed ID: 3124635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
